Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1991 Aug;50(8):553–557. doi: 10.1136/ard.50.8.553

Prevalence of antiphospholipid antibodies in patients with fetal loss.

H J Out 1, H W Bruinse 1, G C Christiaens 1, M van Vliet 1, J F Meilof 1, P G de Groot 1, R J Smeenk 1, R H Derksen 1
PMCID: PMC1004486  PMID: 1888196

Abstract

The prevalence of antiphospholipid and antinuclear antibodies in 102 patients with at least three unexplained miscarriages before a gestational age of 12 weeks, or at least one intrauterine fetal death after 12 weeks, was investigated and compared with the prevalence in 102 normal pregnant controls. Six patients had a history of thrombosis and six had 'lupus-like' disease. Twenty one patients had anticardiolipin antibodies compared with 10 controls. Serum samples of nine patients and one control contained antinuclear antibodies. The lupus anticoagulant was present in the plasma of five patients with anticardiolipin antibodies. The influence of patient selection on the results was illustrated by the finding that antiphospholipid antibodies and antinuclear antibodies were mainly detected in patients with lupus-like disease or a history of thrombosis. When these patients were excluded there was no significant difference in the prevalence of anticardiolipin and antinuclear antibodies between patients and controls. Therefore, in the absence of lupus-like disease or a history of thrombosis, screening for antiphospholipid antibodies in patients with adverse pregnancy outcomes seems not to be indicated.

Full text

PDF
553

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., de Groot E. R., Feltkamp T. E. Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci. 1975 Jun 30;254:505–515. doi: 10.1111/j.1749-6632.1975.tb29197.x. [DOI] [PubMed] [Google Scholar]
  2. Barbui T., Cortelazzo S., Galli M., Parazzini F., Radici E., Rossi E., Finazzi G. Antiphospholipid antibodies in early repeated abortions: a case-controlled study. Fertil Steril. 1988 Oct;50(4):589–592. [PubMed] [Google Scholar]
  3. Branch D. W., Scott J. R., Kochenour N. K., Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med. 1985 Nov 21;313(21):1322–1326. doi: 10.1056/NEJM198511213132104. [DOI] [PubMed] [Google Scholar]
  4. Carreras L. O., Vermylen J., Spitz B., Van Assche A. "Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol. 1981 Sep;88(9):890–894. doi: 10.1111/j.1471-0528.1981.tb02224.x. [DOI] [PubMed] [Google Scholar]
  5. Cowchock S., Fort J., Munoz S., Norberg R., Maddrey W. False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion. Clin Exp Immunol. 1988 Aug;73(2):289–294. [PMC free article] [PubMed] [Google Scholar]
  6. Cowchock S., Smith J. B., Gocial B. Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol. 1986 Nov;155(5):1002–1010. doi: 10.1016/0002-9378(86)90335-2. [DOI] [PubMed] [Google Scholar]
  7. Derksen R. H., Hasselaar P., Blokzijl L., Gmelig Meyling F. H., De Groot P. G. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. Ann Rheum Dis. 1988 May;47(5):364–371. doi: 10.1136/ard.47.5.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Derksen R. H., Kater L. Lupus anticoagulant: revival of an old phenomenon. Clin Exp Rheumatol. 1985 Oct-Dec;3(4):349–357. [PubMed] [Google Scholar]
  9. Edelman P., Rouquette A. M., Verdy E., Elias A., Cabane J., Cornet D., Barrat J., Chavinie J., Salat-Baroux J., Sureau C. Autoimmunity, fetal losses, lupus anticoagulant: beginning of systemic lupus erythematosus or new autoimmune entity with gynaeco-obstetrical expression? Hum Reprod. 1986 Aug;1(5):295–297. doi: 10.1093/oxfordjournals.humrep.a136408. [DOI] [PubMed] [Google Scholar]
  10. Harger J. H., Rabin B. S., Marchese S. G. The prognostic value of antinuclear antibodies in women with recurrent pregnancy losses: a prospective controlled study. Obstet Gynecol. 1989 Mar;73(3 Pt 1):419–424. [PubMed] [Google Scholar]
  11. Harris E. N., Gharavi A. E., Patel S. P., Hughes G. R. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987 Apr;68(1):215–222. [PMC free article] [PubMed] [Google Scholar]
  12. Howard M. A., Firkin B. G., Healy D. L., Choong S. C. Lupus anticoagulant in women with multiple spontaneous miscarriage. Am J Hematol. 1987 Oct;26(2):175–178. doi: 10.1002/ajh.2830260208. [DOI] [PubMed] [Google Scholar]
  13. Kurata N., Tan E. M. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum. 1976 May-Jun;19(3):574–580. doi: 10.1002/art.1780190309. [DOI] [PubMed] [Google Scholar]
  14. Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet. 1983 Jun 18;1(8338):1361–1363. doi: 10.1016/s0140-6736(83)92141-4. [DOI] [PubMed] [Google Scholar]
  15. Maier D. B., Parke A. Subclinical autoimmunity in recurrent aborters. Fertil Steril. 1989 Feb;51(2):280–285. [PubMed] [Google Scholar]
  16. Petri M., Golbus M., Anderson R., Whiting-O'Keefe Q., Corash L., Hellmann D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum. 1987 Jun;30(6):601–606. doi: 10.1002/art.1780300601. [DOI] [PubMed] [Google Scholar]
  17. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  18. Tincani A., Cattaneo R., Martinelli M., Faden D., Tarantini M., Cerri V., Balestrieri G. Antiphospholipid antibodies in recurrent fetal loss: only one side of the coin? Clin Exp Rheumatol. 1987 Oct-Dec;5(4):390–392. [PubMed] [Google Scholar]
  19. Unander A. M., Norberg R., Hahn L., Arfors L. Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion. Am J Obstet Gynecol. 1987 Jan;156(1):114–119. doi: 10.1016/0002-9378(87)90218-3. [DOI] [PubMed] [Google Scholar]
  20. el-Roeiy A., Myers S. A., Gleicher N. The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women. Obstet Gynecol. 1990 Mar;75(3 Pt 1):390–396. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES